Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$193.77 - $244.14 $641,572 - $808,347
-3,311 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$223.92 - $287.77 $562,487 - $722,878
2,512 Added 314.39%
3,311 $794,000
Q3 2021

Nov 10, 2021

SELL
$282.99 - $369.05 $22,356 - $29,154
-79 Reduced 9.0%
799 $226,000
Q2 2021

Aug 12, 2021

BUY
$259.0 - $414.71 $227,402 - $364,115
878 New
878 $304,000
Q1 2021

May 14, 2021

SELL
$242.95 - $284.63 $444,112 - $520,303
-1,828 Closed
0 $0
Q4 2020

Feb 08, 2021

SELL
$236.26 - $355.63 $16,301 - $24,538
-69 Reduced 3.64%
1,828 $448,000
Q3 2020

Nov 12, 2020

SELL
$264.77 - $305.71 $966,940 - $1.12 Million
-3,652 Reduced 65.81%
1,897 $538,000
Q2 2020

Aug 11, 2020

BUY
$258.66 - $342.55 $559,481 - $740,935
2,163 Added 63.88%
5,549 $1.49 Million
Q1 2020

May 08, 2020

SELL
$268.85 - $341.04 $922,962 - $1.17 Million
-3,433 Reduced 50.34%
3,386 $1.07 Million
Q4 2019

Feb 12, 2020

SELL
$220.06 - $304.07 $465,426 - $643,108
-2,115 Reduced 23.67%
6,819 $2.02 Million
Q3 2019

Nov 12, 2019

SELL
$217.44 - $243.88 $489,892 - $549,461
-2,253 Reduced 20.14%
8,934 $2.08 Million
Q2 2019

Jul 30, 2019

BUY
$219.29 - $241.72 $72,146 - $79,525
329 Added 3.03%
11,187 $2.62 Million
Q1 2019

May 13, 2019

BUY
$216.71 - $338.96 $476,762 - $745,712
2,200 Added 25.41%
10,858 $2.57 Million
Q4 2018

Feb 08, 2019

SELL
$278.5 - $352.75 $17,824 - $22,576
-64 Reduced 0.73%
8,658 $2.61 Million
Q3 2018

Nov 07, 2018

SELL
$293.51 - $383.83 $288,226 - $376,921
-982 Reduced 10.12%
8,722 $3.08 Million
Q2 2018

Aug 13, 2018

BUY
$257.52 - $306.91 $1.37 Million - $1.63 Million
5,316 Added 121.15%
9,704 $2.82 Million
Q1 2018

May 04, 2018

BUY
$260.13 - $367.91 $1.14 Million - $1.61 Million
4,388 New
4,388 $1.2 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $23B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Agf Investments LLC Portfolio

Follow Agf Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Agf Investments LLC with notifications on news.